Acompanhe as Notícias da Recifes

Blocking IL1RAP, a receptor that sits at a key control point in inflammatory signaling, can disrupt the tumor-driven inflammatory network that helps pancreatic cancer resist treatment, according to new research. Led by researchers at Sylvester Comprehensive Cancer Center, part of

Pancreatic cancer is one of the deadliest cancers and the third-leading cause of cancer-related death in the United States. While scientists continue searching for new therapies, advances can also come from understanding how existing drugs work. By uncovering the underlying biolo

A new "tumor-on-a-chip" model is giving scientists a live look at how pancreatic cancer can recruit the body's own immune cells to help tumors survive. Researchers say the findings, published in Biofabrication, reveal possible new targets to weaken the cancer's defenses and make

A new Yale-led study published in JNCI Cancer Spectrum is the first to examine the overall relationship between pancreatic cancer and neighborhood-level socioeconomic factors.

A pauta traz uma atualização relevante e serve como base para a cobertura editorial. O recorte ajuda a contextualizar a pauta dentro de Economia.

Pesquisadores da Northwestern Medicine mostraram que um teste de sangue mais sensível pode identificar sinais de câncer de pâncreas que passam despercebidos nos exames tradicionais. A técnica mira mutações no gene KRAS, presente em mais de 90% dos casos.